Study Assessing the Efficacy and Safety of Treatment With Alpelisib Plus Fulvestrant in Japanese Men and Postmenopausal Women With Advanced Breast Cancer
Clinical trial NCT04524000 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04524000
- Sponsor
- Novartis Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-08
- Primary completion
- 2027-02-26
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.